Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title Sort descending | FOA | Organization | Release Date | Expire Date | Purpose |
---|---|---|---|---|---|
Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed) | RFA-TR-24-021 | NCATS | This is a non-competitive funding opportunity intended to fund a single award. NCATS is announcing its intent to issue a single source cooperative agreement to Cincinnati Childrens Hospital Medical… More | ||
Single Source: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Coordination, Analysis, and Scientific Outreach (UM1 Clinical Trial Not Allowed) | RFA-DA-25-015 | NIDA | To establish a Data Center to coordinate and analyze single cell and other molecular data sets generated by Single Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and… More | ||
Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed) | PAR-24-055 | NIGMS | The purpose of this NOFO is to support the NIGMS Human Genetic Cell Repository (HGCR). The repository will maintain the current collection of cell cultures and DNA samples and will acquire,… More | ||
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) | PAR-22-189 | NHLBI | This Funding Opportunity Announcement (FOA) supports applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic… More | ||
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) | RFA-CA-24-023 | NCI | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also… More | ||
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) | PAR-24-133 | NIH | Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an… More | ||
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) | PAR-24-134 | NIH | Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an… More | ||
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) | PAR-24-131 | NIH | Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an… More | ||
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) | PAR-24-132 | NIH | Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an… More | ||
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) | PAR-21-313 | NIDDK | The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical… More |